Cost-Utility Analysis of Geriatric Assessment and Management in Older Adults With Cancer: Economic Evaluation Within 5C Trial.

Yeva Sahakyan Qixuan Li Shabbir Muhammad Husayn Alibhai Martine T E Puts Shant T Yeretzian Mohammed Rashidul Anwar Sarah Brennenstuhl Bianca McLean Fay J Strohschein George A Tomlinson Aria Wills Lusine Abrahamyan

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

To our knowledge, this is the first cost-utility analysis of GAM in cancer. GAM was cost-effective for patients with cancer treated with curative but not with palliative intent. The study provides further considerations for future adoption of GAM in practice.

Keyphrases

papillary thyroid
healthcare
squamous cell
primary care
physical activity
clinical trial
palliative care
study protocol
randomized controlled trial
squamous cell carcinoma
electronic health record
lymph node metastasis
current status